VALIANT LABORATORIES
Back to Cashflow Statement
|
VALIANT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.79 Cr | ₹45 Cr | ₹152 Cr | ₹-0.93 Cr |
What is the latest Cash Flow from Financing Activities ratio of VALIANT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹1.79 Cr |
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹-0.93 Cr |
How is Cash Flow from Financing Activities of VALIANT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.79 Cr | -95.99 | |
| Mar2025 | ₹45 Cr | -70.71 | |
| Mar2024 | ₹152 Cr | Positive | |
| Mar2023 | ₹-0.93 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹657.3 Cr | -2.5% | 1.2% | 50.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -2.5% |
1.2% |
50.3% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses